The significance of platelet-derived growth factors for proliferation of vascular smooth muscle cells
- 1 January 1999
- journal article
- review article
- Published by Taylor & Francis in Platelets
- Vol. 10 (2-3) , 77-96
- https://doi.org/10.1080/09537109909169169
Abstract
Platelets are important in acute thrombotic occlusion of injured vessels, e.g., subsequent to angioplasty. In contrast to these acute events of thrombus formation, much less is known about the significance of platelets for the control of smooth muscle cell (SMC) proliferation. A body of experimental and clinical evidence indicates an involvement of platelets in the pathology of atherosclerosis and restenosis. However, the precise role of platelet-derived growth factors for SMC proliferation in atherosclerotic and restenotic vessels is not clear and many questions remain unresolved. Platelet-dependent SMC mitogenesis is determined by a coordinate action of several classes of mitogenic factors which are either released from storage pools or generated upon platelet activation. Although platelet-derived growth factor (PDGF) is considered to be the most important platelet mitogen it is very likely that yet unknown factors and mechanisms are involved. Differential (stimulatory or inhibitory) effects on SMC growth and differentiation have been reported for different platelet-derived growth factors. Thus, for the overall response, complex interactions between multiple factors need to be considered. In addition, multicellular interactions, e.g., between platelets and endothelial cells may modulate the effects of platelet-derived factors on SMC mitogenesis. Taken together, the mechanisms of platelet-dependent SMC proliferation need to be reevaluated. The assessment of the precise role of platelet mitogens in the complex proliferative repair mechanisms of an injured vessel wall clearly requires further studies.Keywords
This publication has 93 references indexed in Scilit:
- Activation of NFκB Is Essential but Not Sufficient to Stimulate Mitogenesis of Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1997
- Circulating transforming growth factor β1 and coronary artery diseaseCardiovascular Research, 1997
- Transforming Growth Factor β Is a Modulator of Platelet-Derived Growth Factor Action in Vascular Smooth Muscle Cells: A Possible Role for Catalase Activity and Glutathione Peroxidase ActivityBiochemical and Biophysical Research Communications, 1997
- NF-κB Is Induced in the Nuclei of Cultured Rat Aortic Smooth Muscle Cells by Stimulation of Various Growth FactorsBiochemical and Biophysical Research Communications, 1996
- Insulin-like growth factor binding protein-1 inhibits arterial smooth muscle cell proliferation in vitro but does not reduce the neointimal response to balloon catheter injuryAtherosclerosis, 1995
- Involvement of NF-κB Activation in Thrombin-Induced Human Vascular Smooth Muscle Cell ProliferationBiochemical and Biophysical Research Communications, 1994
- L-Arginine Inhibits Balloon Catheter-Induced Intimal HyperplasiaBiochemical and Biophysical Research Communications, 1993
- Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-β) on DNA synthesis in porcine aortic smooth muscle cells in cultureExperimental Cell Research, 1992
- The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human plateletsBiochemical and Biophysical Research Communications, 1988
- Inhibitory effect of transforming growth factor-β on epidermal growth factor-induced proliferation of cultured rat aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 1988